General Info

National Genetics Institute, a subsidiary of LabCorp, was created to meet an evolving market need for comprehensive laboratory testing and information services. Its chief focus is providing laboratory solutions from design specifications through information management and timely delivery of quality results. The company was founded in 1991 to provide clinical trial testing for the pharmaceutical and biotechnology industries. The primary focus of National Genetics Institute is to advance and implement molecular biology techniques used to diagnose and treat genetic and viral illness. Since the company's inception, NGI has focused its expertise using Polymerase Chain Reaction technology for testing AIDS/HIV, hepatitis and cancer. The company has developed a proprietary clinical assay system, based on PCR technology. NGI is licensed and approved as a clinical laboratory provider by both state and federal agencies.